{
    "id": "dbpedia_2460_2",
    "rank": 76,
    "data": {
        "url": "https://ambergen.com/companynews/ambergen-announces-new-appointments-for-john-gillespie-dr-kenneth-j-rothschild/",
        "read_more_link": "",
        "language": "en",
        "title": "AmberGen Announces New Appointments for John Gillespie & Dr. Kenneth J. Rothschild",
        "top_image": "https://ambergen.com/wp-content/themes/ambergen/img/favicon-32x32.png",
        "meta_img": "https://ambergen.com/wp-content/themes/ambergen/img/favicon-32x32.png",
        "images": [
            "https://ambergen.com/wp-content/themes/ambergen/img/page-3dots.png",
            "https://ambergen.com/wp-content/uploads/2024/03/ambergen_logo-wht.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2022-04-25T15:35:57+00:00",
        "summary": "",
        "meta_description": "The Board of Directors has appointed John Gillespie as President and CEO of AmberGen.Â  Dr. Kenneth J. Rothschild, Founder and longtime CEO will become Executive Chairman and accept the newly created position of Chief Innovation Officer.",
        "meta_lang": "en",
        "meta_favicon": "https://ambergen.com/wp-content/themes/ambergen/img/favicon.png",
        "meta_site_name": "AmberGen",
        "canonical_link": "https://ambergen.com/companynews/ambergen-announces-new-appointments-for-john-gillespie-dr-kenneth-j-rothschild/",
        "text": "The Board of Directors has appointed John Gillespie as President and CEO of AmberGen. Dr. Kenneth J. Rothschild, Founder and longtime CEO will become Executive Chairman and accept the newly created position of Chief Innovation Officer."
    }
}